ArticleParkinson's disease2016

Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.

William Seiple et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.